Neuland Laboratories Ltd's Unit 1 successfully completes USFDA inspection

Neuland Laboratories Limited has announced that the United States Food and Drug Administration ("US FDA") has inspected its Unit 1 manufacturing facility at Bonthapally, Hyderabad from 18th to 22nd of March 2024.

The inspection at Unit 1 by the US FDA has been successfully completed, with no observations under Form 483.

Shares of Neuland Laboratories Limited was last trading in BSE at Rs. 6374.15 as compared to the previous close of Rs. 6055.10. The total number of shares traded during the day was 2895 in over 913 trades.

The stock hit an intraday high of Rs. 6452.95 and intraday low of 6049.45. The net turnover during the day was Rs. 18182120.00.

Source : Equity Bulls

Keywords

NeulandLaboratories INE794A01010 USFDA Inspection Unit1 Bonthapally